We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Neurodegeneration Research Aided by New Microscope

By LabMedica International staff writers
Posted on 24 Sep 2008
A new microscope is being utilized to identify very small structures in the brains of fruit flies that are being studied to help to understand how and why motor neuron diseases occur. More...
The illumination system and the fluorescence microscopy of this equipment are assisting with the close examination of fly brains.

Motic (Hong Kong SAR, China) has recently supplied an Epi-Fluorescence BA 400 microscope, which is helping in the study of neurodegenerative diseases, at Kings College London (UK). The fruit flies are being used due to their similarities to human genetic characteristics, and because they have a short life cycle and are genetically reproduced easily.

The research involves closely monitoring the brain function of the fruit flies and using locomotion as a behavioral measurement. Experiments were performed on the fruit flies, such as their ability to climb, to examine the loss of motor neurons with age. A trial of drugs is also being given to the flies to see how they react and if a tremor is identified.

The externally mounted 30W halogen Koehler (Bohemia, NY, USA) illumination system of the microscope provides bright and uniform lighting through the various contrast techniques, enabling close and clear observation of the flies brains. The upright BA 400 inverted-Y-design stand allows an attachment of a reflective Epi-fluorescence illuminator. The microscope has three filter modules in which an additional blank filter module enables the BA 400 to be used as a bright field and phase contrast microscope.

"The Motic Microscope was selected as it fulfilled all our requirements and was an excellent price,” commented Frank Hirth, head of Research Group, at Denmark Hill, Kings College London. "We use the microscope on a daily basis and it enables us to conduct the bulk of our research, thus saving us both time and money before we need to book the slots to use confocal microscopes which are very expensive.”

Graham Moss, from Motic Europe, commented, "We are delighted to be involved in this exciting research on motor neuron diseases. The BA 400 is a versatile microscope as it can easily be transformed into a fluorescence microscopy platform enabling it to be both a space and budget saving device.”

Motic is a hi-tech industrial enterprise specializing in the manufacturing of conventional optical microscopes. Motic is the optical microscope division of Speed Fair Co., Ltd., Hong Kong.

Related Links:
Motic


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.